Cyclophosphamide

£0.00

Cyclophosphamide is a cancer medicine used to treat certain types of leukaemia and lymphoma, and some other cancers. It works by slowing down the growth of fast-growing cancer cells. It may be given as tablets or by injection, depending on your condition and treatment plan. Common side effects can include nausea, tiredness, hair loss, and effects on blood cells. Your healthcare team will monitor you closely during treatment.
Cyclophosphamide (UK) – Patient Information

Cyclophosphamide

Cyclophosphamide is a powerful medicine used to treat certain cancers and some immune-related conditions. It belongs to a group of medicines called alkylating agents. In the body, it is converted into active substances that interfere with the growth and spread of rapidly dividing cells.

This guide explains what cyclophosphamide does, how it works in the body, typical uses, practical tips, safety considerations, and information relevant to customers in the United Kingdom.

Quick product overview

Category Details
Medicine name Cyclophosphamide
How it works Alkylating agent that damages DNA in rapidly dividing cells
Typical forms Tablets or capsules (brand/formulation may vary), and injectable preparations in hospitals
Common uses Cancers (e.g., lymphoma, breast cancer, leukaemias) and selected immune disorders (e.g., some forms of vasculitis, nephrotic syndrome in certain cases)
Monitoring Blood tests (full blood count, kidney and liver function) and urine monitoring may be needed
Key safety points Risk of low blood counts, infection, bladder irritation, nausea, fertility effects, and potential long-term effects

What cyclophosphamide is used for

Cyclophosphamide is used in two broad areas:

1) Cancer treatment

It is used alone or in combination with other medicines as part of chemotherapy. Depending on the condition, the regimen may be given in cycles (periods of treatment followed by rest).

2) Immune-related conditions

Cyclophosphamide may also be used when the immune system is attacking the body (for example, in certain forms of vasculitis or other severe inflammatory conditions). In these settings, it helps to reduce harmful immune activity.

How it works (mechanism of action)

Cyclophosphamide is considered a prodrug, meaning it becomes active after the body converts it. After activation (primarily in the liver), it produces chemical compounds that:

  • Cross-link DNA, preventing cells from copying their genetic material.
  • Disrupt cell division, leading to cell death—especially in rapidly dividing cells.
  • Also reduce immune cell activity, which contributes to its use in selected autoimmune conditions.

Because it affects fast-growing cells, it can also affect healthy cells that divide quickly (such as blood-forming cells, and the lining of the digestive tract), which explains many side effects.

Pharmacokinetics: what happens to the medicine in the body

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates cyclophosphamide. While exact values can vary between individuals, the main points include:

  • Activation: Cyclophosphamide is metabolised in the liver into active cytotoxic metabolites.
  • Distribution: Active metabolites circulate and can reach target tissues, including the bloodstream and lymphoid tissues.
  • Elimination: The metabolites are cleared through the kidneys. This is one reason urine-related side effects (e.g., bladder irritation) are important.
  • Half-life: The time it takes for drug levels to fall can vary, influenced by liver function, treatment regimen, and other medicines.

Because cyclophosphamide is processed through the liver and excreted by the kidneys, your clinician may adjust the dose if you have liver impairment or kidney impairment.

Indications (what it is prescribed for)

In the UK, cyclophosphamide may be used for a range of conditions under specialist care. These commonly include:

  • Lymphomas and other haematological cancers
  • Some solid tumours (often as part of combination regimens)
  • Leukaemias in certain treatment plans
  • Severe immune-mediated disorders (for example, certain types of vasculitis or kidney inflammation related to immune activity)

The exact “which cancers or conditions” depend on the clinical protocol and your individual medical situation. Always follow your specialist’s treatment plan.

Dosing: how cyclophosphamide is typically taken

Cyclophosphamide dosing depends on:

  • The condition being treated
  • Your body weight, height, and/or body surface area (BSA), where relevant
  • Whether it is used in combination with other chemotherapy medicines
  • Blood test results (especially white blood cells and platelets)
  • Liver and kidney function
  • The intended schedule (for example, daily, weekly, or in cycles)

Doses may be adjusted to reduce the risk of severe side effects. Your treatment team will determine the specific dose and schedule.

Timing: when to take your dose

If you are taking cyclophosphamide as an oral medicine (tablets/capsules), timing depends on the regimen. In many cases, it is taken at the same time each day to keep drug exposure consistent. Treatment may be given in cycles (e.g., treatment days followed by rest).

  • Try to take it at consistent times each day if prescribed daily.
  • Do not change the schedule without your clinician’s advice.
  • If you miss a dose, contact your healthcare team for guidance rather than doubling up.

Food interactions

Food can influence absorption for some medicines. For cyclophosphamide, practical guidance commonly includes:

  • Follow the instructions on your specific product label regarding taking with or without food.
  • If you experience nausea, your clinician may suggest taking it with a small snack (if compatible with your regimen).

Always check your local product instructions and advice from your pharmacy team, because formulations and schedules differ.

Alcohol interactions

Alcohol may affect:

  • Liver metabolism (relevant because cyclophosphamide is processed in the liver)
  • Hydration and stomach tolerance (relevant if you experience nausea or vomiting)
  • Infection risk and general resilience during cancer treatment

There is no single “safe amount” that applies to everyone. It is generally recommended to discuss alcohol use with your clinician, especially if you have liver problems, abnormal blood counts, or active treatment cycles.

Medicine interactions: key interactions to be aware of

Cyclophosphamide can interact with other medicines in ways that affect side effects, effectiveness, or blood counts. Examples of interaction categories include:

  • Medicines that affect liver enzymes: Some drugs can alter cyclophosphamide activation/metabolism.
  • Medicines that affect bone marrow: Other chemotherapy or immune-suppressing drugs may increase low blood count risk.
  • Warfarin and anticoagulants: Treatment changes can affect clotting and bleeding risk, and blood count changes may influence management.
  • Other nephrotoxic medicines: If kidney function is affected, overall risk may rise.
  • Live vaccines and certain immunisations: Immune suppression may make live vaccines unsafe during treatment.

Inform your pharmacy team about all medicines you take, including:

  • Prescription medicines
  • Over-the-counter products (including pain relief)
  • Herbal supplements (some can affect liver enzymes)
  • Any recent antibiotics or antifungals

Safety profile: common and serious side effects

Cyclophosphamide can be effective, but it also has important safety considerations. Side effects often relate to its impact on fast-dividing cells and its effects on organs involved in metabolism and elimination.

Common side effects

  • Nausea and vomiting
  • Loss of appetite
  • Hair thinning or hair loss (varies by regimen)
  • Fatigue
  • Low blood counts (neutropenia/anaemia/thrombocytopenia), which can lead to infection, tiredness, or bruising
  • Stomach discomfort
  • Bladder irritation or discomfort (haemorrhagic cystitis risk in some situations)

Serious risks (seek medical advice promptly)

  • Signs of infection: fever, chills, sore throat, or feeling unusually unwell
  • Bleeding or bruising more easily than normal
  • Blood in urine, burning on urination, or severe lower abdominal pain
  • Severe allergic reactions: swelling of face/lips, rash, breathing difficulties
  • Breathlessness or chest pain (urgent assessment needed)
  • Severe or persistent vomiting or inability to keep fluids down

Fertility and pregnancy considerations

Cyclophosphamide may affect fertility. It can also be harmful to an unborn baby. If you may become pregnant, are trying to conceive, or are planning fertility preservation, discuss options with your clinical team before treatment.

  • Use effective contraception as advised by your specialist.
  • Do not stop contraception early without medical advice.
  • If you have concerns about fertility, ask about fertility preservation before starting treatment.

Long-term risks

Some people may face long-term risks depending on dose and duration, including secondary malignancies and chronic organ effects. Your clinician can explain the risks in the context of your treatment plan and alternatives.

Practical use tips for patients

The following tips can help make treatment safer and more manageable:

During treatment

  • Keep scheduled blood tests and monitoring appointments. They help prevent complications from low blood counts.
  • Hydration matters: ask your team whether you should increase fluid intake and whether any protective medicines are needed (some regimens include bladder-protective measures).
  • Report urinary symptoms early: burning, frequent urination, blood in urine, or pain should be assessed promptly.
  • Manage nausea: use anti-sickness medicines as prescribed and eat small, bland meals if tolerated.
  • Avoid exposure to infections: follow advice on hygiene and, where relevant, protective measures for people around you.

Handling tablets/capsules safely

If you are taking oral cyclophosphamide at home, follow guidance for safe handling. Many cancer medicines require careful precautions to reduce exposure risk.

  • Wash hands before and after handling.
  • Do not crush or open tablets/capsules unless your pharmacy confirms this is appropriate for your product.
  • If there is accidental spillage, follow pharmacy instructions for cleaning.

Driving and operating machinery

Cyclophosphamide can cause fatigue or dizziness in some people, especially if combined with other medicines. Avoid driving or operating machinery if you feel unwell.

Alternative options

Depending on your diagnosis and treatment goals, alternatives may include other chemotherapy or immunosuppressive medicines, or different combinations. Your specialist may consider:

  • Other chemotherapy regimens (based on cancer type and stage)
  • Different immunosuppressants for immune-mediated conditions
  • Targeted therapies or radiotherapy where appropriate
  • Supportive therapies (for example, anti-sickness medicines, growth factors, or bladder-protective strategies)

The best alternative depends on clinical factors. Discuss options with your treating team.

United Kingdom market and legal context

In the UK, cyclophosphamide is a medicine used in specialist settings and is regulated under medicines law. Many cancer and immunosuppressive medicines require careful prescribing and monitoring due to the risk of serious side effects.

Availability can vary by formulation and whether treatment is delivered in hospital oncology or via outpatient services. Supply may be coordinated by the treating healthcare provider and pharmacy services.

Recent guidance and monitoring approach (high-level)

Treatment practices are informed by oncology and immunology guidelines, including careful monitoring of:

  • Blood counts to reduce risks of infection and bleeding
  • Organ function (kidney and liver)
  • Urinary symptoms due to bladder irritation risk
  • Infection prevention measures, including guidance on vaccinations
  • Supportive care to manage nausea and maintain hydration

Your clinical team may also consider patient-specific risk factors (age, co-morbidities, concurrent medicines, and prior treatments).

Delivery and availability (UK)

Availability of cyclophosphamide can depend on the specific strength, formulation, and the clinical pathway for your treatment. When supplied by a pharmacy, availability checks may be needed before dispatch.

  • Delivery: Delivery options vary by service provider and your location in the UK.
  • Packaging: Products are typically supplied in sealed packaging with manufacturer instructions.
  • Storage: Store according to the label instructions (commonly at room temperature, away from moisture and out of sight and reach of children).

If you need the medicine urgently due to your treatment schedule, contact customer support so the pharmacy can advise on the fastest options available.

FAQ

1) How does cyclophosphamide make cancer treatment work?

Cyclophosphamide damages DNA in rapidly dividing cells. This prevents cancer cells from growing and dividing. It may also suppress parts of the immune system, which is helpful in certain immune-related disorders.

2) What monitoring will I need while taking it?

You may have frequent blood tests (full blood count) and checks of kidney and liver function. Urine symptoms are monitored because bladder irritation can occur in some regimens. The schedule depends on your specific protocol.

3) What should I do if I miss a dose?

Do not double up. Contact your healthcare team or pharmacy for advice specific to your treatment schedule and timing. Cyclophosphamide regimens vary, so the correct approach depends on your plan.

4) Can I take cyclophosphamide with food?

Follow the product instructions and advice from your healthcare team. Some people prefer taking it with food to reduce nausea, but this can depend on formulation and regimen.

5) Are vaccinations safe during treatment?

Immune suppression may affect which vaccines are appropriate. Live vaccines are often avoided during chemotherapy and immune suppression. Ask your clinician or pharmacist about which vaccines you can receive.

6) What urine symptoms are most important to report?

Report promptly: blood in urine, burning or pain when passing urine, increased frequency, or lower abdominal pain. Early assessment can help prevent complications.

7) Will cyclophosphamide cause hair loss?

Hair loss or thinning can happen, but it varies depending on the dose and combination with other medicines. Not everyone experiences the same degree of hair changes.

8) How long does cyclophosphamide take to start working?

Treatment response depends on the condition. Some effects occur quickly at the cellular level, but visible clinical response may take weeks and may be assessed over multiple treatment cycles.

9) Can I drink alcohol while taking cyclophosphamide?

Alcohol may increase liver-related stress and worsen stomach side effects. Discuss alcohol use with your clinician, particularly if you have liver issues or significant side effects.

10) What are the most urgent side effects?

Seek urgent medical help for signs of infection (especially fever), significant bleeding or bruising, severe allergic reactions, blood in urine, or severe breathing/chest symptoms.

11) Are there alternatives to cyclophosphamide?

Yes—depending on your diagnosis. Alternatives may include other chemotherapy regimens, targeted treatments, radiotherapy, or other immunosuppressive medicines. Your specialist can advise based on your specific condition.

Important safety notice

This information is provided to help you understand cyclophosphamide and how it is commonly used. It does not replace advice from a qualified healthcare professional. If you have concerns about side effects, interactions, or missed doses, contact your healthcare team promptly.

Additional information

Dosage: No selection

50mg

Package: No selection

30 pill, 60 pill, 90 pill, 120 pill, 180 pill, 360 pill